Stock Institutional Ownership and Shareholders

SecurityPPHMP / Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock (713661403)
President & CEOKING STEVEN W
Institutional Owners2
Institutional Shares226,998
Outstanding Shares44,773,727 (as of 2017-07-31)
Related PPHM / Peregrine Pharmaceuticals, Inc.

Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock (NASDAQ:PPHMP) has 2 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 226,998 shares. Largest shareholders include Stafford John S Iii, and Ronin Capital, LLC.


Peregrine Pharmaceuticals, 10.50% Ser E Cumulative Convertible Preferred Stock (NASDAQ:PPHMP) ownership summary shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev Shares Current Shares Change
(Percent)
Prev Value (x$1000) Current Value (x$1000) Change
(Percent)
2017-05-19 SC 13D/A Ronin Capital, LLC 95,059 111,699 17.50
2017-10-27 SC 13D/A STAFFORD JOHN S III 115,299 115,299 0.00
2017-08-14 13F-HR PERCEPTIVE ADVISORS LLC 200,000 0 -100.00 4,342 0 -100.00
2017-04-28 13F-HR Burt Wealth Advisors 600 0 -100.00 12 0 -100.00
CUSIP: 713661403